Clinical Trials Search
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation | Calcium and vitamin D, Pamidronate | NCT02074631 | Masonic Cancer Center, University of Minnesota | Recruiting |
| PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... | Laboratory Biomarker Analysis, Placebo, Rilimogene Galvacirepvec | NCT02326805 | National Cancer Institute (NCI) | Active, not recruiting |
| Radiation Therapy in Treating Patients With Prostate Cancer | 36.25 Gy IMRT, 51.6 Gy IMRT | NCT01434290 | Radiation Therapy Oncology Group | Active, not recruiting |
| Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... | Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine | NCT02568566 | National Cancer Institute (NCI) | Active, not recruiting |
| Relaxation for Women With Breast Cancer Undergoing Radiotherapy | Saliva Testing, Questionnaires, Relaxation Program | NCT01202851 | M.D. Anderson Cancer Center | Active, not recruiting |
| Reproductive Health Program in Patients With Cancer | educational intervention, questionnaire administration, quality-of-life assessment | NCT01806129 | Eastern Cooperative Oncology Group | Recruiting |
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer | Retinoid 9cUAB30, Therapeutic Conventional Surgery | NCT02876640 | National Cancer Institute (NCI) | Recruiting |
| S0820, Adenoma and Second Primary Prevention Trial | Eflornithine placebo & sulindac placebo, eflornithine & sulindac placebo, Eflornithine placebo & sulindac, Eflornithine plus sulindac | NCT01349881 | Southwest Oncology Group | Recruiting |
| S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and... | therapeutic conventional surgery, gastrointestinal complications management/prevention, quality-of-life assessment | NCT02270450 | Southwest Oncology Group | Recruiting |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) | Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration | NCT02728596 | Southwest Oncology Group | Recruiting |